Obesity

Metabolic Health and Heterogenous Outcomes of Prenatal Interventions: A Secondary Analysis of a Randomized Clinical Trial

JAMA Netw OpenPublished Secondary analysis of the LIFE-Moms randomised trials

Authors' conclusion

In this preplanned secondary analysis of a randomized clinical trial of an IBT on GWG among pregnant individuals, those with MUO experienced less GWG, had a higher incidence of gestational diabetes, and had infants with a higher proportion of adiposity compared with those who MHO. Data supported that the maternal obesity metabolic phenotype has a greater clinical effect on adverse maternal and infant clinical outcomes compared with GWG alone and did not contribute to a differential response to a lifestyle intervention. Future interventions should identify methods to better optimize the maternal metabolic milieu as early in pregnancy as possible to reduce the intergenerational transmission of metabolic disease.

Study context

Population
Pregnant women with obesity, viable singleton pregnancy, no previous cardiometabolic disease; mean age 30.2 years, mean BMI 35.2
Participants
640 women
Comparison
MUO vs MHO phenotype
  • MUOn = 172
  • MHOn = 228reference
Primary endpoint
GWG (total and adherence to guidelines), adverse perinatal outcomes, substrate changes and infant body composition
Methodological detailspreplanned secondary analysis, consortium of 7 multicenter RCTs, intention-to-treat
  • Preplanned secondary analysis
  • Consortium of 7 multicenter RCTs
  • Intention-to-treat

Primary result

As reported in the abstract

Response to treatment by phenotype
  • MUO and MHO did not differ in response to treatment in weight outcomes, adverse perinatal outcomes or substrate changes, except smaller TG increases with intervention more in MUO than MHO
  • Intention-to-treat

Further findings

GWG (adjusted) · lower with MUO

difference 36.7% · P < 0.001

Exceeded weight gain guidelines

P = 0.03

GDM

P = 0.001

Infant adiposity (% fat)

P = 0.05

Mean

OutcomeMUOMHOP value
TG increase in intervention group, by phenotype90.3% (SE 7.4%)81.8% (SE 8.3%)P = 0.02
  • Gestational weight gain (GWG) (adjusted): adjusted for maternal baseline demographics and treatment group

Original publication

Metabolic Health and Heterogenous Outcomes of Prenatal Interventions: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. Published 1 August 2025. doi:10.1001/jamanetworkopen.2025.28264

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.